Literature DB >> 4759102

Foetal bile pigment handling after administration of (14C)haemin.

B T Jackson, R Lester, J M Little, G J Piasecki, H F Rauschecker, P M Smith.   

Abstract

1. Advanced techniques for intra-uterine surgery were used to study haem degradation in foetal sheep prepared in utero with indwelling jugular, carotid and biliary cannulas. [(14)C]haemin was administered I.V. to the foetus, and plasma disappearance, biliary excretion, placental transfer and tissue distribution of radioactivity were measured over a 5-8 hr period.2. 8-30% of the (14)C-label was recovered in foetal bile, about 40% of this as bilirubin and the rest as unidentified [(14)C]haemin derivatives. 4-21% was transferred across the placenta, appearing in maternal bile almost exclusively as [(14)C]bilirubin. Excretion of (14)C-label totalled 18-33%.3. Six adult sheep infused with [(14)C]haemin excreted 19-49% of the dose in the bile over 8 hr, one third as bilirubin.4. The amount of endogenous bilirubin excreted per unit time/unit wt. of foetal liver increased with increasing foetal wt.5. It is concluded that near-term foetal sheep have a maturing mechanism for haem catabolism. Haem is partially excreted in foetal bile as bilirubin. Another fraction is transferred across the placenta, probably after prior conversion to bilirubin. The remainder is converted to un-identifiable end-products. Total excretion is approximately as effective as that in adults.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4759102      PMCID: PMC1350536          DOI: 10.1113/jphysiol.1973.sp010294

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  19 in total

1.  DEFECTS IN HEPATIC TRANSPORT OF BILIRUBIN IN CONGENITAL HYPERBILIRUBINAEMIA: AN ANALYSIS OF PLASMA BILIRUBIN DISAPPEARANCE CURVES.

Authors:  B H BILLING; R WILLIAMS; T G RICHARDS
Journal:  Clin Sci       Date:  1964-10       Impact factor: 6.124

2.  TRANSFER OF BILIRUBIN-C14 ACROSS MONKEY PLACENTA.

Authors:  R LESTER; R E BEHRMAN; J F LUCEY
Journal:  Pediatrics       Date:  1963-09       Impact factor: 7.124

3.  THE CONVERSION OF HEMATIN TO BILE PIGMENT IN THE RAT.

Authors:  A L SNYDER; R SCHMID
Journal:  J Lab Clin Med       Date:  1965-05

4.  The performance of complex fetal operations in utero without amniotic fluid loss or other disturbances of fetal-maternal relationships.

Authors:  B T JACKSON; R H EGDAHL
Journal:  Surgery       Date:  1960-09       Impact factor: 3.982

5.  Direct lead fetal electrocardiography with undisturbed fetal-maternal relationships.

Authors:  B T JACKSON; J P CLARKE; R H EGDAHL
Journal:  Surg Gynecol Obstet       Date:  1960-06

6.  A new method of hemin isolation.

Authors:  R F LABBE; G NISHIDA
Journal:  Biochim Biophys Acta       Date:  1957-11

7.  The formation of bilirubin from hemoglobin in vivo.

Authors:  J D OSTROW; J H JANDL; R SCHMID
Journal:  J Clin Invest       Date:  1962-08       Impact factor: 14.808

8.  Oxygen flask combustion in determination of C-14 and H3 in biological materials.

Authors:  V T OLIVERIO; C DENHAM; J D DAVIDSON
Journal:  Anal Biochem       Date:  1962-08       Impact factor: 3.365

9.  The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase.

Authors:  R Tenhunen; H S Marver; R Schmid
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

10.  Experimental bilirubin encephalopathy. The mode of entry of bilirubin-14C into the central nervous system.

Authors:  I Diamond; R Schmid
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

View more
  2 in total

1.  Protohemin in bile during primate development.

Authors:  S G Blumenthal; B H Ruebner; R M Ikeda; F W Hanson; D E Bergstrom
Journal:  Experientia       Date:  1977-05-15

2.  'Electrochemical stimulation' of the hypothalamus--a demonstration that this technique does not cause the direct excitation of peptidergic neurones [proceedings].

Authors:  R G Dyer
Journal:  J Physiol       Date:  1978-11       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.